Stay updated on Lazertinib Combination in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check12 days agoChange DetectedThe study record shows updates in April 2026, with the latest posting dated 2026-04-13. These changes appear to be metadata updates rather than substantive changes to the study's design or results.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedLocation entries were updated to reflect language and postcode corrections. Boston, MA 02115 and Naples, Italy 80131 were added, while Boston 02215 and Napoli 80131 were removed.SummaryDifference0.3%

- Check48 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous v3.4.1; no other content or navigation changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedA version tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.